Pregnancies with blood disorders at greater risk of serious complications
The study showed immune thrombocytopenia caused most maternal near-miss cases, especially when platelet counts dropped below 50×10⁹/L.
The study showed immune thrombocytopenia caused most maternal near-miss cases, especially when platelet counts dropped below 50×10⁹/L.
A novel mutation, revealed by advanced genetic analysis, caused fetal and neonatal alloimmune thrombocytopenia (FNAIT) in a newborn.
Nipocalimab’s success in gMG may bode well for its efficacy in treating FNAIT, a serious fetal condition with no approved therapies.
Nearly one in three babies born to mothers with Glanzmann’s thrombasthenia developed FNAIT in a recent study.
Very premature infants exposed to preeclampsia needed more platelet transfusions even though FNAIT was not observed in the sample.
A recent case report highlighted how a well-planned approach can help prevent FNAIT in pregnancies at higher risk.
Neuroprotection bundles, including proper positioning, pain management and respiratory support, can help prevent IVH.
COVID-19 infection at any stage of pregnancy did not lead to worse health outcomes for mothers or infants in a recent study in China.
Posttransfusion purpura is a rare but serious immune response that can lead to severe platelet loss and bleeding.
In a recent case study, maternal antibodies likely transferred through breastfeeding caused delayed thrombocytopenia in a newborn.